The future of metabolomics in ELIXIR

Author:

van Rijswijk MerlijnORCID,Beirnaert CharlieORCID,Caron Christophe,Cascante Marta,Dominguez VictoriaORCID,Dunn Warwick B.,Ebbels Timothy M. D.,Giacomoni Franck,Gonzalez-Beltran AlejandraORCID,Hankemeier Thomas,Haug KennethORCID,Izquierdo-Garcia Jose L.,Jimenez Rafael C.ORCID,Jourdan Fabien,Kale NamrataORCID,Klapa Maria I.ORCID,Kohlbacher OliverORCID,Koort Kairi,Kultima Kim,Le Corguillé GildasORCID,Moschonas Nicholas K.ORCID,Neumann Steffen,O’Donovan Claire,Reczko Martin,Rocca-Serra Philippe,Rosato AntonioORCID,Salek Reza M.ORCID,Sansone Susanna-AssuntaORCID,Satagopam VenkataORCID,Schober DanielORCID,Shimmo Ruth,Spicer Rachel A.ORCID,Spjuth OlaORCID,Thévenot Etienne A.ORCID,Viant Mark R.,Weber Ralf J. M.,Willighagen Egon L.ORCID,Zanetti Gianluigi,Steinbeck ChristophORCID

Abstract

Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.

Funder

Horizon 2020

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Flux balance analysis of metabolic networks for efficient engineering of microbial cell factories;Biotechnology and Genetic Engineering Reviews;2022-12-07

2. Emerging technologies and their impact on regulatory science;Experimental Biology and Medicine;2021-11-16

3. Bacting: a next generation, command line version of Bioclipse;Journal of Open Source Software;2021-06-23

4. Capillary Electrophoresis-Mass Spectrometry for Metabolomics: Possibilities and Perspectives;Advances in Experimental Medicine and Biology;2021

5. NMR-Based Metabolomics;Comprehensive Foodomics;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3